| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 09/19/2006 | US7109013 Cellulase preparation containing nonionic surfactant and method of treating fiber |
| 09/19/2006 | US7109012 Recombinant lysophosphatidic acid phosphatase |
| 09/19/2006 | US7109010 Isolated nucleic acid encoding a yeast lactate dehydrogenate protein; use in production of lactic acid |
| 09/19/2006 | US7109009 Comprises nucleotide sequences coding enzymatic polypeptide for producing intermediates associated with thermoplastics, plasticizing agents, lubricants, hydraulic fluids, dyes, agricultural hemicals, pharmaceuticals and adhesives |
| 09/19/2006 | US7109008 L-glutamate oxidase |
| 09/19/2006 | US7108999 Nucleotide sequences coding protein for use in treating eating disorder, autoimmune and viral diseases |
| 09/19/2006 | US7108998 Nucleic acid fragment encoding an NRPS for the biosynthesis of anthramycin |
| 09/19/2006 | US7108991 Receptors whose endogenous ligand has not been identified (orphan) |
| 09/19/2006 | US7108989 Therapy |
| 09/19/2006 | US7108979 Methods to detect cross-contamination between samples contacted with a multi-array substrate |
| 09/19/2006 | US7108978 Detecting the presence of a single nucleotide polymorphism in a CD81 gene (SEQ ID NO: 46) and determining that said individual has said propensity to respond effectively to said, treatment of interferon- alpha and ribavirin combined therapy if said single nucleotide polymorphism is present |
| 09/19/2006 | US7108975 Atlastin |
| 09/19/2006 | US7108974 Detecting bacteria or viral nucleotide sequences; restriction fragment length polymorphism; fourier transform ion cyclotron resonance mass spectrometry (FT-ICR-MS); ion trap; time of flight |
| 09/19/2006 | US7108973 Human PEN11B-related gene variant associated with lung cancers |
| 09/19/2006 | US7108971 For use in hybridization/purification/immunoassays/biosensors; solid phase synthesis |
| 09/19/2006 | US7108968 Mycobacterial rpoB sequences |
| 09/19/2006 | US7108854 Also an antibody which specifically binds to the protein and a Hybridoma cell line that produces the protein; immunoprophylactic uses |
| 09/19/2006 | US7108853 Surface protein of Leptospira |
| 09/19/2006 | US7108844 Use of stabilized oligonucleotides for preparing a medicament with antitumor activity |
| 09/18/2006 | CA2501253A1 Means and methods for individualized drug therapy and for predicting adverse drug reaction |
| 09/14/2006 | WO2006096515A2 Modified transferrin fusion proteins |
| 09/14/2006 | WO2006096459A2 Infectious, chimeric hepatitis c virus, methods of producing the same and methods of use thereof |
| 09/14/2006 | WO2006096392A2 Enzymes involved in astaxanthin, carotenoid and isoprenoid biosynthetic pathways, genes encoding them and methods of making and using them |
| 09/14/2006 | WO2006096214A1 Environmentally stable sensors and methods of using the same |
| 09/14/2006 | WO2006096213A1 Polyamine sensors and methods of using the same |
| 09/14/2006 | WO2006095981A1 Processes using dual specificity oligonucleotide and dual specificity oligonucleotide |
| 09/14/2006 | WO2006095831A1 Probe and carrier having probe immobilized thereon |
| 09/14/2006 | WO2006095830A1 Linker compound, probe, and carrier having probe immobilized thereon |
| 09/14/2006 | WO2006094963A1 Synthesis of oligonucleotides |
| 09/14/2006 | WO2006094406A1 Antisense oligonucleotides targeted to the coding region of thymidylate synthase and uses thereof |
| 09/14/2006 | WO2006066439A3 Rna-sequence or nucleoside/nucleotide analogues and method for producing the analogues |
| 09/14/2006 | WO2006047311A3 Cloning of the retinoic acid inducible gene-1 promoter and uses thereof |
| 09/14/2006 | WO2005117964A3 Cynomolgus prostate specific antigen |
| 09/14/2006 | WO2005104813A3 Method of identifying hairpin dna probes by partial fold analysis |
| 09/14/2006 | WO2005086667A3 High efficiency peptide production in plant cells |
| 09/14/2006 | WO2005079331A3 Methods and compositions for inferring eye color and hair color |
| 09/14/2006 | WO2005077091A8 Nicotinamide riboside kinase compositions and methods for using the same |
| 09/14/2006 | WO2005065418A3 Compositions and methods of use of targeting peptides for diagnosis and therapy |
| 09/14/2006 | WO2005007121A3 Mutant interleukin-2(il-2) polypeptides |
| 09/14/2006 | WO2004108066A3 Neuronal regeneration and compound administration methods |
| 09/14/2006 | WO2004094655A3 Modulation of telomere-initiated cell signaling |
| 09/14/2006 | WO2004037192A3 Identification of antimycobacterial targets and the inhibition thereof as a treatment for infectious diseases |
| 09/14/2006 | WO2003095614A3 Cytokine polypeptides |
| 09/14/2006 | WO2003089588A3 Novel molecules of the pyrin/nbs/lrr protein family and uses thereof |
| 09/14/2006 | WO2003072759A3 Cloning and characterization of slc26a6, slc26a1, and slc26a2 anion exchangers |
| 09/14/2006 | WO2003002721A3 Compositions and methods for inferring a response to a statin |
| 09/14/2006 | US20060206967 Genetic control of flowering |
| 09/14/2006 | US20060206962 Preparation of deallergenized proteins and permuteins |
| 09/14/2006 | US20060206960 Higher plant cytosolic er-based glycerol-3-phosphate acyltransferase genes |
| 09/14/2006 | US20060206958 Transforming a plant or plant cell with a nucleotide sequence operably linked to a promoter active in plant cells encoding an NRC1 protein and forming a transgenic plant; family Solanaceae, genus Solanum; cells, seeds, fruits |
| 09/14/2006 | US20060206957 Converting farnesyl-pyrophosphate to patchoulol, gamma -curcumene and other germacrane-type sesquiterpenes; vectors; host cells |
| 09/14/2006 | US20060206954 Polynucleotide that expresses a polypeptide having AP2 domain; plant transcription regulators contain a DNA binding domain called the AP2 domain; use in genetic engineering of plants, host cells |
| 09/14/2006 | US20060206950 In vivo imaging of e2f-fegulated bioluminescent proteins |
| 09/14/2006 | US20060206948 C-Reactive Protein (CRP); peptide biodrugs used to reduce body weight, adiposity, and alleviate insulin resistance and diabetes |
| 09/14/2006 | US20060206947 Heterodimeric protein binding compositions |
| 09/14/2006 | US20060205934 Compositions, splice variants and methods relating to breast specific genes and proteins |
| 09/14/2006 | US20060205933 Pon polypeptides polynucleotides encoding same and compositions and methods utilizing same |
| 09/14/2006 | US20060205926 Human growth hormone domains |
| 09/14/2006 | US20060205925 Inhibits hemolysis by interacting with the plasma proteins clusterin; histidine rich glycoprotein (HRG); Streptococcal Inhibitor of Complement-mediated lysis |
| 09/14/2006 | US20060205924 Spliced variants of lgr6 |
| 09/14/2006 | US20060205668 For therapy of spinal cord injury or stroke, by overcoming the inhibitory effects of myelin on axonal regeneration |
| 09/14/2006 | US20060205660 OB protein-immunoglobulin chimeras |
| 09/14/2006 | US20060205654 Screening methods for identifying disorders related to huXAG-1, huXAG-2 or huXAG-3 (colon cancer specific gene) activity |
| 09/14/2006 | US20060205653 protein that potentiates toxin activity of a Class A toxin complex protein against an insect; insecticides |
| 09/14/2006 | US20060205641 VANILREP4 polypeptides and VANILREP4 polynucleotides |
| 09/14/2006 | US20060205068 Useful in identifying and designing novel Bt toxin receptor ligands including novel insecticidal toxins; manipulating Bt toxin susceptibility in plant pests |
| 09/14/2006 | US20060205067 Vector that produces a fusion protein of an antigen with a Listerial truncated ActA protein; use making vaccines |
| 09/14/2006 | US20060205053 phosphatidyl-glycerolphosphate synthase; used to identify compounds that act as agonists and antagonists and modulate the expression of the novel PGP synthase; for drug screening |
| 09/14/2006 | US20060205052 Bardet-Biedl susceptibility gene and uses thereof |
| 09/14/2006 | US20060205046 Nucleotide sequences which code for the zwa1 gene |
| 09/14/2006 | US20060205045 Which produces N-alkyl-L-alanine from pyruvic acid and alkylamine or dialkylamine using NADPH and/or NADH as coenzyme; biosynthesis |
| 09/14/2006 | US20060205042 Novel variant hypocrea jecorina CBH2 cellulases |
| 09/14/2006 | US20060205041 Recombinant bovine thrombin |
| 09/14/2006 | US20060205038 antagonist antibody that blocks binding of IL-17; degenerative cartilaginous disorders and other inflammatory diseases |
| 09/14/2006 | US20060205037 Modified transferrin fusion proteins |
| 09/14/2006 | US20060205036 Coagulation Factor VII polypeptides |
| 09/14/2006 | US20060205035 Expression vectors; transformed host cells; culturing the host cell to produce the encoded polypeptide; antiasthmatic agents |
| 09/14/2006 | US20060205034 Expression vector comprising nucleotide sequences coding membrane protein for identifying modulators for prevention and treatment of lung, gastrointestinal and cell proliferative disorders |
| 09/14/2006 | US20060205032 hSLIM modulates immune responses |
| 09/14/2006 | US20060205031 Newly identified cholinephosphotransferases and ethanolaminephosphotransferases |
| 09/14/2006 | US20060205030 Hydantoinase; carbamylases; nutraceuticals; animal feeds/husbandry |
| 09/14/2006 | US20060205020 Cell-cycle checkpoint genes |
| 09/14/2006 | US20060205017 Microorganism genomics, compositions and methods related thereto |
| 09/14/2006 | US20060205016 Protein a based binding domains with desirable activities |
| 09/14/2006 | US20060205004 Reversible association of nucleic acid with a carboxylated substrate |
| 09/14/2006 | US20060204998 Alleles of the human mu opioid receptor, diagnostic methods using said alleles, and methods of treatment based thereon |
| 09/14/2006 | US20060204996 Method of designing primer and probe sets, primer and probe set designed by the method, kit comprising the sets, computer readable medium recorded thereon program to execute the method, and method of identifying target sequence using the sets |
| 09/14/2006 | US20060204995 Method of designing probe set, probe set designed by the method, microarray comprising the probe set, computer readable medium recorded thereon program to execute the method, and method of identifying target sequence using the probe set |
| 09/14/2006 | US20060204994 Novel human protein kinases and protein kinase-like enzymes |
| 09/14/2006 | US20060204990 Compounds and methods for fluorescent labeling |
| 09/14/2006 | US20060204987 Applications with and methods for producing selected interstrand cross-links in nucleic acids |
| 09/14/2006 | US20060204985 Method of hybridizing genes |
| 09/14/2006 | US20060204977 oligonucleotides used for detection and analyzing analytes in solution |
| 09/14/2006 | US20060204974 Screening agents for post-transcriptional control of angiotensin receptors; hypotensive agents |
| 09/14/2006 | US20060204969 Genetic variations (SNPs) adjacent to the AKT1 gene locus, and diagnostic and prognostic uses thereof |
| 09/14/2006 | US20060204967 Methods for identifying risk of breast cancer and treatments thereof |
| 09/14/2006 | US20060204964 Molecular detection systems utilizing reiterative oligonucleotide synthesis |
| 09/14/2006 | US20060204963 Nucleotide sequences of coryneform bacteria coding for proteins involved in l-serine metabolism and method for producing l-serine |
| 09/14/2006 | US20060204962 Genetic polymorphisms as predictive diagnostics for adverse drug reactions (adr) and drug efficacy |
| 09/14/2006 | US20060204961 Reagents and methods for diagnosis of attention deficit hyperactivity disorder |